Clinical Trial

Treatment Hypertension to Recommended Levels in Old Patients

Study acronym: THReshOld
Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated March 10, 2025 (before its estimated June 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
After checking the patient characteristics to the inclusion and exclusion criteria, and confirming the ability to complete the questionnaires provided by the study protocol, patients will be randomly assigned to 2 groups: a group with a higher target BP level (less than 135 mmHg) and a lower target BP level (less than 125 mmHg). Achievement of target BP levels will be assessed using a remote monitoring system. The study will identify factors that prevent achievement of target BP levels, as well as assess the efficacy, safety and tolerability of antihypertensive therapy (AHT).
Trial Details
NCT Number NCT06865846
Lead Sponsor I.M. Sechenov First Moscow State Medical University
Collaborators: Russian Gerontological Scientific and Clinical Center, Pirogov Russian National Research Medical University
Conditions Arterial Hypertension
Enrollment 60 participants
Start Date 2024-04-01
Primary Completion 2025-06-01 (estimated)
Study Completion 2025-07-01 (estimated)
Updated on ClinicalTrials.gov 2025-03-10